Compare ALEMBIC LTD with Procter & Gamble Health - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs PROCTER & GAMBLE HEALTH - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

PROCTER & GAMBLE HEALTH 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD PROCTER & GAMBLE HEALTH ALEMBIC LTD/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 66.8 52.9 126.2% View Chart
P/BV x 2.4 4.8 49.5% View Chart
Dividend Yield % 0.4 9.9 4.3%  

Financials

 ALEMBIC LTD   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
PROCTER & GAMBLE HEALTH
Dec-18
ALEMBIC LTD/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs723,549 2.0%   
Low Rs341,301 2.6%   
Sales per share (Unadj.) Rs4.7511.4 0.9%  
Earnings per share (Unadj.) Rs6.161.3 10.0%  
Cash flow per share (Unadj.) Rs6.274.0 8.4%  
Dividends per share (Unadj.) Rs0.20440.00 0.0%  
Dividend yield (eoy) %0.418.1 2.1%  
Book value per share (Unadj.) Rs40.7927.8 4.4%  
Shares outstanding (eoy) m267.0316.60 1,608.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.34.7 237.6%   
Avg P/E ratio x8.739.6 21.9%  
P/CF ratio (eoy) x8.532.8 25.9%  
Price / Book Value ratio x1.32.6 49.8%  
Dividend payout %3.3717.9 0.5%   
Avg Mkt Cap Rs m14,13940,257 35.1%   
No. of employees `000NA1.1 0.0%   
Total wages/salary Rs m2071,313 15.8%   
Avg. sales/employee Rs ThNM7,486.7-  
Avg. wages/employee Rs ThNM1,157.6-  
Avg. net profit/employee Rs ThNM897.2-  
INCOME DATA
Net Sales Rs m1,2558,490 14.8%  
Other income Rs m370244 151.8%   
Total revenues Rs m1,6258,734 18.6%   
Gross profit Rs m1111,482 7.5%  
Depreciation Rs m38211 17.9%   
Interest Rs m20-   
Profit before tax Rs m4421,514 29.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m066 0.0%   
Tax Rs m24563 4.3%   
Profit after tax Rs m1,6301,017 160.2%  
Gross profit margin %8.917.5 50.7%  
Effective tax rate %5.437.1 14.6%   
Net profit margin %129.812.0 1,083.5%  
BALANCE SHEET DATA
Current assets Rs m1,86715,343 12.2%   
Current liabilities Rs m5911,960 30.2%   
Net working cap to sales %101.6157.6 64.5%  
Current ratio x3.27.8 40.3%  
Inventory Days Days9449 193.4%  
Debtors Days Days7428 258.5%  
Net fixed assets Rs m1,7911,209 148.1%   
Share capital Rs m534166 321.7%   
"Free" reserves Rs m10,32415,235 67.8%   
Net worth Rs m10,85815,401 70.5%   
Long term debt Rs m410-   
Total assets Rs m11,59117,595 65.9%  
Interest coverage x260.9NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.10.5 22.4%   
Return on assets %14.15.8 243.4%  
Return on equity %15.06.6 227.2%  
Return on capital %15.210.3 148.1%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m191,636 1.2%   
Fx outflow Rs m2644,368 6.0%   
Net fx Rs m-244-2,732 8.9%   
CASH FLOW
From Operations Rs m236-1,304 -18.1%  
From Investments Rs m-22412,697 -1.8%  
From Financial Activity Rs m-27-301 8.9%  
Net Cashflow Rs m-1511,093 -0.1%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 0.2 18.2 1.1%  
FIIs % 9.7 1.0 970.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 29.1 89.7%  
Shareholders   54,701 28,591 191.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   PFIZER  GSK PHARMA  PANACEA BIOTECH  WYETH LTD  ABBOTT INDIA  

Compare ALEMBIC LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends above 39,000-Mark; Automobile and Banking Stocks Witness Buying(Closing)

Extending gains to the fifth day, Indian share markets rose sharply during the afternoon session and ended on a strong note.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Oct 17, 2019 03:37 PM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS